Press releases

Positive results presented at Digestive Disease Week 2008

New size allows for treatment of smaller-diameter diseased saphenous vein grafts

ACUITY® Spiral lead has smallest left ventricular lead tip profile in the industry

Results of international, multi-center registry to be presented at conference

ALTITUDE clinical science initiative will provide insights to ICD and CRT-D device therapy

COGNIS™ CRT-D and TELIGEN™ ICD represent entirely new platforms

Provides valuable insights for diabetic patients, who are often at higher risk for adverse events and repeat stenting procedures

Boston Scientific welcomed two-year results from the SPIRIT III clinical trial, presented at the 2008 EuroPCR Scientific Program in Barcelona.

Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention

"We are very pleased with the decision by the Canadian Federal Court dismissing this case," said Boston Scientific's Chief Operating Officer.

ALTRUA™ is Company's most advanced pacemaker and delivers enhanced therapies while maintaining its small size and battery longevity.

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...

Ruling from World Intellectual Property Organization (WIPO) arbitration panel finds no infringement

A live webcast and replay of the May 6 conference session will be available

A live webcast and replay of the April 30 session will be available.

MADIT-CRT trial designed to test whether CRT-Ds can slow the progression of heart failure in heart attack survivors

Award recognizes Boston Scientific's successful use of electronic transactions to improve supply chain efficiency for customers and suppliers

"We continued to make good progress during the quarter, particularly in our efforts to bring expenses in line with revenues," said CEO Jim Tobin.

Company plans to launch product immediately

Acquisition follows a 2007 development agreement to pursue therapeutic solutions for atrial fibrillation, or "Afib"

Emerging technology will potentially enable access to MRI exams for implantable cardiac device patients

ACUITY® Steerable lead also receives reimbursement approval; Company plans to launch product immediately

A live webcast and replay of the April 22 conference call will be available.

Nationally known attorney specializing in medical device and pharmaceutical litigation; will serve on the Company's Executive Committee

Judgment entered in favor of Guidant and its former directors/officers